InvestorsHub Logo
Followers 17
Posts 2085
Boards Moderated 1
Alias Born 09/27/2020

Re: None

Thursday, 10/03/2024 6:41:26 AM

Thursday, October 03, 2024 6:41:26 AM

Post# of 8631
Novavax Form 8-K filed 10/3/24

Form 8-K

Novavax, Inc. (“Novavax”) is aware of an analyst report published on October 1, 2024, which referred to discussions with Novavax’s management regarding, among other things, the anticipated U.S. market for COVID-19 vaccination for the 2024-2025 vaccination season. Novavax would like to clarify that while it has anticipated the COVID-19 vaccination market in the U.S. will be similar to last year, it has neither updated nor reaffirmed its full year 2024 financial guidance issued on August 8, 2024.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NVAX News